日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Spatially-resolved subtype progression reveals metabolic vulnerabilities in pancreatic ductal adenocarcinoma

空间分辨的亚型进展揭示了胰腺导管腺癌的代谢脆弱性

Schmitt, Alexandra Maria; Gätje, Fabio Bennet; Tran, Michelle Yi Ran; Midelashvili, Teona; Xu, Xingbo; Fleischer, Johannes Robert; Spahn, Henrik; Lai, Kelvin; Tacke, Tobias; Younes, Sara; Mittlmeier, Anne; Schulze, Olaf; Hasanovic, Kaida; Blume, Moritz Leander; Rotter, Sara Marie; Tesch, Theon Robin; Schneider, Carolin; Todorovic, Jovan; Bohnenberger, Hanibal; Kueffer, Stefan; Ströbel, Philipp; Papantonis, Argyris; Sax, Ulrich; Agorku, David; Rüberg, Silvia; Yassouri, Fabio El; Purushothaman, Rajeshwaran; Warratz, Svenja; Ferreira, Nathalia; Schneider, Günter; Igelmann, Sebastian; Planque, Melanie; Fendt, Sarah-Maria; Ghadimi, Michael; Hessmann, Elisabeth; Ackermann, Lutz; De Oliveira, Tiago; Conradi, Lena-Christin

TP53 missense-specific transcriptional plasticity drives resistance against cell cycle inhibitors in pancreatic cancer

TP53错义突变特异性转录可塑性驱动胰腺癌对细胞周期抑制剂产生耐药性

Urbach, Laura; Wieland, Lena; Penz, Frederike; Samuel, Rebecca Diya; Küffer, Stefan; Klein, Lukas; Lenz, Christof; Sax, Ulrich; Ghadimi, Michael; Schulz-Heddergott, Ramona; Hessmann, Elisabeth; Ellenrieder, Volker; Dusetti, Nelson; Singh, Shiv K

Simultaneous targeting of KRAS and CDK4 synergistically induces durable growth arrest in pancreatic cancer cells.

同时靶向 KRAS 和 CDK4 可协同诱导胰腺癌细胞持久生长停滞。

Paulsohn Maj-Britt, Frahnert Klara Henrike, Schlösser Denise, Oschwald Joana, Kopp Waltraut, Fang Xin, Schneider Carolin, Tapia Contreras Constanza, Danieli-Mackay Adi, Ludewig Fabian, Bleyer Martina, Salinas Gabriela, Schneider Günter, Hessmann Elisabeth, Dobbelstein Matthias

Epigenetic control of pancreatic cancer metastasis

胰腺癌转移的表观遗传调控

Krauß, Lukas; Schneider, Carolin; Hessmann, Elisabeth; Saur, Dieter; Schneider, Günter

NFATc1 signaling drives chronic ER stress responses to promote NAFLD progression

NFATc1信号通路驱动慢性内质网应激反应,从而促进非酒精性脂肪性肝病(NAFLD)的进展。

Latif, Muhammad Umair; Schmidt, Geske Elisabeth; Mercan, Sercan; Rahman, Raza; Gibhardt, Christine Silvia; Stejerean-Todoran, Ioana; Reutlinger, Kristina; Hessmann, Elisabeth; Singh, Shiv K; Moeed, Abdul; Rehman, Abdul; Butt, Umer Javed; Bohnenberger, Hanibal; Stroebel, Philipp; Bremer, Sebastian Christopher; Neesse, Albrecht; Bogeski, Ivan; Ellenrieder, Volker

Epigenetic Therapeutic Strategies to Target Molecular and Cellular Heterogeneity in Pancreatic Cancer

针对胰腺癌分子和细胞异质性的表观遗传治疗策略

Versemann, Lennart; Hessmann, Elisabeth; Ulisse, Maria

To be or not to be

生存还是毁灭

Zhang, Zhe; Hessmann, Elisabeth

Epigenetic treatment of pancreatic cancer: is there a therapeutic perspective on the horizon?

胰腺癌的表观遗传治疗:治疗前景如何?

Hessmann, Elisabeth; Johnsen, Steven A; Siveke, Jens T; Ellenrieder, Volker

Histone deacetylase class-I inhibition promotes epithelial gene expression in pancreatic cancer cells in a BRD4- and MYC-dependent manner.

组蛋白去乙酰化酶 I 类抑制以 BRD4 和 MYC 依赖的方式促进胰腺癌细胞中上皮基因的表达

Mishra Vivek Kumar, Wegwitz Florian, Kosinsky Robyn Laura, Sen Madhobi, Baumgartner Roland, Wulff Tanja, Siveke Jens T, Schildhaus Hans-Ulrich, Najafova Zeynab, Kari Vijayalakshmi, Kohlhof Hella, Hessmann Elisabeth, Johnsen Steven A

GSK-3β Governs Inflammation-Induced NFATc2 Signaling Hubs to Promote Pancreatic Cancer Progression

GSK-3β调控炎症诱导的NFATc2信号通路,促进胰腺癌进展

Baumgart, Sandra; Chen, Nai-Ming; Zhang, Jin-San; Billadeau, Daniel D; Gaisina, Irina N; Kozikowski, Alan P; Singh, Shiv K; Fink, Daniel; Ströbel, Philipp; Klindt, Caroline; Zhang, Lizhi; Bamlet, William R; Koenig, Alexander; Hessmann, Elisabeth; Gress, Thomas M; Ellenrieder, Volker; Neesse, Albrecht